<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, we tested the effects of the additional proton pump inhibitors pantoprazole, rabeprazole, lansoprazole, and dexlansoprazole (
 <xref rid="B25" ref-type="bibr">Li et al., 2017</xref>) on CPE formation in HSV-1-infected HaCaT cells. All tested proton pump inhibitors increased the activity of acyclovir (
 <xref ref-type="fig" rid="F4">Figure 4</xref> and 
 <xref ref-type="supplementary-material" rid="SM5">Supplementary Table S4</xref>), which suggests that this is a drug class effect.
</p>
